Motor neuron hyperexcitability (MNH) indicates a disorder characterized by an ectopic motor nerve discharge on electromyogram (EMG). Here, we present a series of three cases of subacute MNH with mercury poisoning. The first case showed hyperhidrosis, insomnia, generalied myokymia, cramps, tremor, weight loss, and myokymic and neuromyotonic discharges, followed by encephalopathy with confusion, hallucinations, and memory decrease. The second case was similar to the former but without encephalopathic features. The third case showed widespread fasciculation, fatigue, insomnia, weight loss, and autonomic dysfunction, including constipation, micturition difficulty, and impotence, with multiple fibrillation, unstable fasciculation, widened motor neuron potential, and an incremental response at high-rate stimulation in repetitive nerve stimulation. Based on the symptoms, the three cases were diagnosed as Morvan's syndrome, Isaacs' syndrome, and Lambert-Eaton myasthenic syndrome with ALS-like syndrome, respectively. Mercury poisoning in the three cases was confirmed by analysis of blood and urine samples. All cases recovered several months after chelation therapy and were in good condition at follow-up. Very few cases of MNH linked with mercury exposure have been reported in the literature. The mechanism of mercury-induced MNH may be associated with ion channel dysfunction.

1.
Caress JB, Walker FO: The spectrum of ectopic motor nerve behavior: from fasciculations to neuromyotonia. Neurologist 2002;8:41-46.
2.
Gutmann L, Libell D, Gutmann L: When is myokymia neuromyotonia? Muscle Nerve 2001;24:151-153.
3.
Isaacs H: A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.
4.
Abou-Zeid E, Boursoulian LJ, Metzer WS, Gundogdu B: Morvan syndrome: a case report and review of the literature. J Clin Neuromuscul Dis 2012;13:214-227.
5.
Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A: Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012;72:241-255.
6.
Nicholson D, Scalettar R, Jacobs RP: Rheumatoid rigor: gold induced myokymia. A report and review of the literature. J Rheumatol 1986;13:195-196.
7.
Hill A, Bergin P, Hanning F, Thompson P, Findlay M, Damianovich D, McKeage MJ: Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer 2010;10:451.
8.
Bolamperti L, Mula M, Varrasi C, Tarletti R, Cavanna A, Monaco F, Cantello R: Generalized peripheral nerve hyperexcitability associated with lithium. J Neuropsychiatry Clin Neurosci 2009;21:346-347.
9.
Reeback J, Benton S, Swash M, Schwartz MS: Penicillamine-induced neuromyotonia. Br Med J 1979;1:1464-1465.
10.
Haug BA, Schoenle PW, Karch BJ, Bardosi A, Holzgraefe M: Morvan's fibrillary chorea. A case with possible manganese poisoning. Clin Neurol Neurosurg 1989;91:53-59.
11.
Graeme KA, Pollack CV Jr: Heavy metal toxicity, Part I: arsenic and mercury. J Emerg Med 1998;16:45-56.
12.
Chan TY: Inorganic mercury poisoning associated with skin-lightening cosmetic products. Clin Toxicol (Phila) 2011;49:886-891.
13.
Yuan X, Chapman RL, Wu Z: Analytical methods for heavy metals in herbal medicines. Phytochem Anal 2011;22:189-198.
14.
Liu J, Shi JZ, Yu LM, Goyer RA, Waalkes MP: Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? Exp Biol Med (Maywood) 2008;233:810-817.
15.
Oz SG, Tozlu M, Yalcin SS, Sozen T, Guven GS: Mercury vapor inhalation and poisoning of a family. Inhal Toxicol 2012;24:652-658.
16.
Praline J, Guennoc AM, Limousin N, Hallak H, de Toffol B, Corcia P: ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg 2007;109:880-883.
17.
Schwarz S, Husstedt I, Bertram HP, Kuchelmeister K: Amyotrophic lateral sclerosis after accidental injection of mercury. J Neurol Neurosurg Psychiatry 1996;60:698.
18.
Brown IA: Chronic mercurialism; A cause of the clinical syndrome of amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry 1954;72:674-681.
19.
Adams CA, Ziegler DK, Lin JT: Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA 1983;250:642-643.
20.
Barber TE: Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med 1978;20:667-669.
21.
Kantarjian AD: A syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism. Neurology 1961;11:639-644.
22.
Yamada M, Inaba A, Shiojiri T: X-linked spinal and bulbar muscular atrophy with myasthenic symptoms. J Neurol Sci 1997;146:183-185.
23.
Titulaer MJ, Lang B, Verschuuren JJ: Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 2011;10:1098-1107.
24.
Kimura F, Smith RG, Delbono O, Nyormoi O, Schneider T, Nastainczyk W, Hofmann F, Stefani E, Appel SH: Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol 1994;35:164-171.
25.
Ogawa E, Sakakibara R, Kawashima K, Yoshida T, Kishi M, Tateno F, Kataoka M, Kawashima T, Yamamoto M: VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo. Neurol Sci 2011;32:1209-1212.
26.
Pamphlett R, Waley P: Uptake of inorganic mercury by the human brain. Acta Neuropathol 1996;92:525-527.
27.
Pamphlett R, Waley P: Motor neuron uptake of low dose inorganic mercury. J Neurol Sci 1996;135:63-67.
28.
Arvidson B: Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motoneurons. Muscle Nerve 1992;15:1089-1094.
29.
Atchison WD: Effects of toxic environmental contaminants on voltage-gated calcium channel function: from past to present. J Bioenerg Biomembr 2003;35:507-532.
30.
Büsselberg D: Calcium channels as target sites of heavy metals. Toxicol Lett 1995;82-83:255-261.
31.
Gallagher JD, Noelle RJ, McCann FV: Mercury suppression of a potassium current in human B lymphocytes. Cell Signal 1995;7:31-38.
32.
Dyatlov VA, Platoshin AV, Lawrence DA, Carpenter DO: Mercury (Hg 2+) enhances the depressant effect of kainate on Ca-inactivated potassium current in telencephalic cells derived from chick embryos. Toxicol Appl Pharmacol 1996;138:285-297.
33.
Liang GH, Järlebark L, Ulfendahl M, Moore EJ: Mercury (Hg2+) suppression of potassium currents of outer hair cells. Neurotoxicol Teratol 2003;25:349-359.
34.
Neustadt J, Pieczenik S: Heavy-metal toxicity - with emphasis on mercury. Integr Med (Encinitas) 2011;10:45-51.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.